Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$15.15
0.886.17%
At close: Aug 12, 5:00 PM EST
Generate Biomedicines Inc
GENBNASDAQ
Earnings: Q2 2026 Earnings were released on Thu Aug 6th, before the market open
Generate Biomedicines Market Sentiment
Market sentiment signals for Generate Biomedicines (GENB): analyst consensus, short interest, options flow and insider activity.
Key Signals
Analyst Consensus▲ Buy
Short Interest▼ 9.8% short float
Options Flow— N/A
Insider Activity— N/A
Analyst Consensus
Buy
6 analysts
Options Flow (P/C)
—
Avg Consensus PT
$25
+67.7%
Highest Price Target
$30
+98.0%
Guggenheim
Lowest Price Target
$22
+45.2%
Morgan Stanley
Short Interest
9.8%
Rising — Bearish
Insider Activity (30d)
—
Short Interest — % of Float
Recent Analyst Actions
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| May 14, 2026 | Morgan Stanley | Sean Laaman— | +45.2% | $20 → $22 | Maintained | Overweight |
| May 8, 2026 | HC Wainwright & Co. | Mitchell S. Kapoor— | +65.0% | $16 → $25 | Maintained | Buy |
